Engineering nano‐clustered multivalent agonists to cross‐link TNF receptors for cancer therapy
Abstract Tumor necrosis factor receptors (TNFRs) are promising targets for cancer therapy. However, activating their downstream signaling requires cross‐linking of TNFRs. Herein, to devise strong agonists of TNFRs, ligands targeting TNFRs, such as OX40L and tumor necrosis factor‐related apoptosis‐in...
| الحاوية / القاعدة: | Aggregate |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Wiley
2023-12-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1002/agt2.393 |